Latest Biosimilar Stories

2014-05-27 23:13:40

In an upcoming webinar from Atlantic Information Services, participants will learn how to manage specialty drug coupons without compromising patient access. Washington,

2014-05-21 23:03:36

New research report “The Future of Biosimilars: mapping critical uncertainties and the impact of future events” by FirstWord is now available at MarketPublishers.com. London,

2014-05-20 12:34:14

DUBLIN, May 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9trl4k/11th_annual)

2014-05-19 08:29:14

PASADENA, Calif., May 19, 2014 /PRNewswire/ -- Meditope Biosciences, Inc., a biotechnology company developing novel

2014-05-19 08:28:28

REDWOOD CITY, Calif., May 19, 2014 /PRNewswire/ -- Coherus BioSciences, Inc.

2014-05-13 16:29:25

DUBLIN, May 13, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has received final approval from the U.S.

2014-05-12 08:31:48

REDWOOD CITY, Calif., May 12, 2014 /PRNewswire/ -- Coherus Biosciences, Inc. ("Coherus"), is pleased to announce the appointment of Lisa M. Bell, Ph.D.

2014-05-12 08:31:42

DUBLIN, May 12, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Valeant Pharmaceuticals International to settle all outstanding patent

2014-05-10 23:01:06

Many pharmaceutical manufacturers will likely derive sales volumes from biological drugs, while also contending with the entrance of biosimilar, or generic biological drugs, into the market.

Word of the Day
  • An imitative word; an onomatopoetic word.
The word 'onomatope' is a back-formation from 'onomatopoeia'.